How much do you know about the history of contraceptive innovation? Take GHTC's World Contraception Day quiz to test your knowledge.

To enjoy a bit of fun and mischief this Halloween, we’ve created a game, TRICK or TREATment, to test our readers’ knowledge of global health technologies.

On February 15, President Trump signed into law a bipartisan spending bill—averting another partial government shutdown and ensuring full-year funding for the government for the remainder of fiscal year 2019. The months-long saga ended with some great news for global health and research and development.

For many mothers and babies around the world, the first 48 hours after birth are the most dangerous of their lives. For eight years, Saving Lives at Birth—spearheaded by USAID—has challenged problem solvers worldwide to create innovative solutions to make birth safer and save lives. Here are ten incredible innovations from this initiative:

As we close out our 10th anniversary year, we wanted to take a moment to reflect on our shared progress and celebrate the headlines and moments that shaped global health R&D over the past decade. Check out some of the highlights...

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

What do an onsite chlorine generator, fingerprint scanning technology for newborns, and temperature-monitoring wristband all have in common? The potential to save the lives of mothers and newborns in some of the poorest, hardest-to-reach communities around the world.

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

In the spirit of the Thanksgiving holiday, GHTC asked our members and staff to share what they are most thankful for in global health.

During the pitches at the Saving Lives at Birth DevelopmentXChange, the questions being asked were not how large the market, but how great the need, and not how much money can be made, but how many lives could be saved.

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Gavi, the Vaccine Alliance, signed an advanced purchase commitment, pledging to spend US$5 million on an Ebola vaccine currently under development by pharmaceutical company Merck & Co.

As 2015 draws to a close, the Global Health Technologies Coalition is reflecting on the past year in global health innovation.

Virginia Commonwealth University (VCU) received a grant from the Global Alliance to Prevent Prematurity and Stillbirth, a member of the GHTC, to study the human microbiome in search of biomarkers to predict preterm birth.

Findings of a study presented at the American Society of Tropical Medicine and Hygiene Annual Meeting last week suggest that ivermectin—a drug long used to treat river blindness and elephantiasis—can combat malaria when used in mass drug administration programs.

Dr. Robert Gallo co-discovered the HIV virus and subsequently led the development of the first HIV and AIDS blood test.

A new briefing paper from the Infectious Diseases Society of America Center for Global Health Policy explores the state of tuberculosis (TB) research and development (R&D) including challenges for products currently in the pipeline and gaps in TB research.